Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

BACKGROUND: Concurrent chemoradiotherapy is a valuable treatment option for localised oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was initiated to assess the feasibility and efficacy in terms of the endoscopic complete response rate (ECRR) of radiotherapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, T, Yataghène, Y, Etienne, P L, Michel, P, Senellart, H, Raoul, J L, Mineur, L, Rives, M, Mirabel, X, Lamezec, B, Rio, E, Le Prisé, E, Peiffert, D, Adenis, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990616/
https://www.ncbi.nlm.nih.gov/pubmed/20940718
http://dx.doi.org/10.1038/sj.bjc.6605943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990616/
https://www.ncbi.nlm.nih.gov/pubmed/20940718
http://dx.doi.org/10.1038/sj.bjc.6605943

Ejemplares similares